Meeting Overview - The shareholders' meeting of Nanjing Weisi Medical Technology Co., Ltd. was held on May 16, 2025, at the company's conference room in Nanjing [1] - A total of 30 ordinary shareholders attended the meeting, holding 63,795,327 voting rights, which represents 66.65% of the company's total voting rights [1] Voting Results - All non-cumulative voting proposals were approved with a significant majority. For instance, 63,788,547 votes (99.9893%) were in favor, while only 6,780 votes (0.0107%) were against [2][3] - The voting process was conducted in accordance with the Company Law and the company's articles of association, utilizing both on-site and online voting methods [1] Legal Compliance - The meeting was presided over by the chairman, Wang Zhiyu, and all procedures followed legal requirements, ensuring the validity of the resolutions made during the meeting [3][4] - The legal opinions were provided by lawyers Qi Kaibing and Xu Rongrong, confirming that the meeting's procedures and resolutions were lawful and effective [3][4]
伟思医疗: 南京伟思医疗科技股份有限公司2024年年度股东大会决议公告